Timber Pharmaceuticals, Inc. TMBR

Set alert

Price alert · TMBR

All alert types
0.34 +0.34 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
1.18M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.06
Beta
-0.65
Short ratio
0.21
Inst. own
7.79%
Dividend
0.00
Ex-div date
Earnings
Dec 4, 2023
50-d avg
1.88
200-d avg
2.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TMBR has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00

Recommendation trend

  • 1 month ago 1
  • 2 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TMBR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.26-1.26 – -1.26-2.50+49.6%00.0%1
Next quarter-1.30-1.30 – -1.30-7.50+82.7%00.0%1
Current year-5.20-5.20 – -5.20-9.19+43.4%00.0%1
Next year-5.51-5.51 – -5.51-5.20-6.0%00.0%1

Upgrades and downgrades

The latest rating changes

TMBR analyst upgrades and downgrades
DateFirmActionFromTo
Aug 27, 2023HC Wainwright & Co.DowngradeBuyNeutral
Apr 9, 2023HC Wainwright & Co.Reiterated—Buy